Detalhe da pesquisa
1.
The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.
Blood
; 142(10): 903-917, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319434
2.
SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Blood
; 135(25): 2271-2285, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202636
3.
Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis.
Proc Natl Acad Sci U S A
; 116(3): 890-899, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30593567
4.
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.
Leukemia
; 37(1): 164-177, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352191
5.
Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia.
Cell Res
; 32(12): 1105-1123, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302855
6.
Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma.
Cell Death Dis
; 12(10): 900, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599153
7.
Comparison between recombinant human parathyroid hormone (1-34) and elcatonin in treatment of primary osteoporosis.
Asian Pac J Trop Med
; 8(1): 79-84, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25901930